InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,942.47
(
1.26%
)
US TECH 100
20,762.73
(
1.73%
)
Dow Jones
42,732.13
(
0.80%
)
Brent Oil
76.50
(
0.00%
)
Bitcoin
97,411.64
(
-0.81%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

healthywelth

Send PM Follow Ignore
Followers 3
Posts 582
Boards Moderated 0
Alias Born 01/19/2012

healthywelth

Re: KStickandMove post# 2642

Wednesday, 08/17/2016 8:24:22 PM

Wednesday, August 17, 2016 8:24:22 PM

Post# of 20617
YES, Its good mistake or prediction , NEVER saw Zacks cover OTC pink stock ... something COOKING . !!!! Innovus Pharmaceuticals Inc (NASDAQ:INNV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday. The brokerage presently has a $0.50 target price on the stock. Zacks Investment Research’s target price suggests a potential upside of 27.88% from the company’s current price
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up